PIK3CB and head and neck squamous cell carcinoma: Similarly, TILs from patients with HNSCC (head and neck squamous cell cancers) refractory to anti-PD-1 therapy demonstrated an enhanced exhaustion phenotype with TIM-3 upregulation that appears to be mediated by PI3K-Akt pathway activity (218).